Nurix Therapeutics, Inc.

Presenting
Tuesday, January 12, 2021
Room
Track 3
Speakers
Arthur Sands Chief Executive Officer, Nurix Therapeutics, Inc.
Hans van Houte Chief Financial Officer, Nurix Therapeutics, Inc.
Robert Brown SVP, Clinical Development, Nurix Therapeutics, Inc.
Analyst
Eric Joseph US - Biotechnology Smid Cap, J.P. Morgan

Expired

The recording of this session is not available any more.



J.P. Morgan conference webinars are intended only for clients of J.P. Morgan’s Corporate and Investment Bank. Unless otherwise specified, conference webinars are on-the-record and open to registered members of the press. For important disclosures on all companies covered by the firm’s research department, please refer to the following disclosure link: https://jpmm.com/research/disclosures.